{"name":"Watson Laboratories, Inc.","slug":"watson-laboratories-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Clindamycin Phosphate / Benzoyl Peroxide Gel","genericName":"Clindamycin Phosphate / Benzoyl Peroxide Gel","slug":"clindamycin-phosphate-benzoyl-peroxide-gel","indication":"Acne vulgaris","status":"phase_3"}]}],"pipeline":[{"name":"Clindamycin Phosphate / Benzoyl Peroxide Gel","genericName":"Clindamycin Phosphate / Benzoyl Peroxide Gel","slug":"clindamycin-phosphate-benzoyl-peroxide-gel","phase":"phase_3","mechanism":"Clindamycin reduces acne-causing bacteria while benzoyl peroxide provides antimicrobial and keratolytic effects to treat acne vulgaris.","indications":["Acne vulgaris"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQTDhzM1pJS0dsV0ZDdGktam03MXFKUE1xd3FtYjltSmFJVFdzX1dWOWFwVklXN3RnZ3pWb01oZklZcHdweTZQYkpIWXZoVmx1RDlON29oZWNUSHUtZGtPalExWF8zLUdPWUo2SEY3SVR3VXRZb0lMaWc5T2RDc294N2x2Wi12dW5idzhGSlJkYm1KLTVCMjBsSGVXVW4zb2hPZUpqRjFUVDJOclBHUlgwQUJlSW5ONEpyUl9uRjVzQmVpdnFic0hwUW9B?oc=5","date":"2025-08-26","type":"pipeline","source":"BioSpace","summary":"Zephyr AI Appoints Watson Pharmaceuticals Founder Dr. Allen Chao as Chief Executive Officer - BioSpace","headline":"Zephyr AI Appoints Watson Pharmaceuticals Founder Dr. Allen Chao as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPQjBwUWE1TmxIc1FncWh0ZnYxMGtXTFlTekZRN3B3Ym1YQktIZEZqeG5iNjNzbGZsWlI1bmM5UTNQaVVORlJvdDBvRmhqdjk5LUpqX3o1NW9pSVgtOHBoUEQyN2ZHUkpzNElmZmI4UXJsd3JBS191RjlURUtackprVVlyeHQ4bEdTQzR6dnNycG9fWFhBNm9OZTA1dDBJYXF5LU9jWVZGUnFhWDg?oc=5","date":"2021-07-04","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Watson now third largest generics company with Actavis acquisition - Generics and Biosimilars Initiative","headline":"Watson now third largest generics company with Actavis acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPNzh3QkJWQkVEUTM0YmhZejRNcXpVeGJyLXFxQ1lXdFhEampfQXJ1dC1KVUhmU1RCTHlTRVpuOE9ZVnBEVjRkZ3lQVTdFLWJ3c1BnRlcydjlnUjFQOUszeXVvTFNCOVlqamdEdkdTRExlR3Vac2Nlb3Vjc1JSSUlMbVZ1MkJUZ2ltRklrdGtmR0UxdWFpalVyZXdDWkVNMVozTEotRXViS3RjNW13LVJWS0J3cw?oc=5","date":"2020-05-17","type":"pipeline","source":"Healthcare Digital","summary":"Watson Pharma sells Rugby's OTC products to Harvard Drug co - Healthcare Digital","headline":"Watson Pharma sells Rugby's OTC products to Harvard Drug co","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxQX1R2dmtBUlMtNHplY2NZTTBlNy1idFNyZzFYOFNKNFg0RVJ5VDBndENlNkk5dHRKZ05zUy1CLUxDRWFEMmhPUEh0Rzk1SHo0Z042ZV9Qdy14OUxneHBNZ0xzRXRGRUJRekQ2S1BTVGVlSjFNcFI1N1RoSklGY21JX1RlWWpZN2NkLVJibkVqb1Y2LXA5dGVCWTVJbUY4cUdDdlVpMHlsRFdzZHdYTUo0allZM2ZxMFJvZGlNa1pIeWJGdHRGWkZaNXg0bFdiSHp4OTRkLVgxNkE1WlhtNXJtYzlMMlNSLXBlaTdsWkNzUFB0aUd4c0ppYmhLVnFKUjdCbHI5YUh1RU9hWmUxOW5Pc3R0VkphTzRkVUlYQU9xNjVFNk53?oc=5","date":"2020-01-06","type":"pipeline","source":"PR Newswire","summary":"Warner Chilcott and Watson Resolve Antitrust Class Action Litigation with Direct and Indirect Purchasers of Loestrin 24 Fe and Minastrin 24 Fe - PR Newswire","headline":"Warner Chilcott and Watson Resolve Antitrust Class Action Litigation with Direct and Indirect Purchasers of Loestrin 24 ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOQ0k0YUJ2RlRPenB5bDhJeHByRWs1cUtTaWVhdnRXNnpsSjdpYU53MU5zay1XNF9zVlVFdVNFS2xwSjYyZHF0VW0wSEFnck5XdmJzcWdvUmZSTUpkbUY5WWZzSnBXejNOaXdIZFpjanRxRUJuR2FZQXFyY01TZ1V5SXpwRkY0aUFGc3lSYXloWDRkRllCazJIbERxVnpTX2pTOUpTQUg1RlAtT1E?oc=5","date":"2017-11-17","type":"regulatory","source":"IPWatchdog.com","summary":"Specific Intent to Induce Patent Infringement Inferred from Pharmaceutical Label - IPWatchdog.com","headline":"Specific Intent to Induce Patent Infringement Inferred from Pharmaceutical Label","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOcHpNS3J0cU1JN0Y4MVNESjQyYmd2RXhVZW9CdEM4TUs1aDlTZ3BnZi1WQnJVRVJsSFZhT1ZyWVZpY3V5ZHpPY3VlZHUzV0MwdXZRWWtvTy1NNXVseFU2VlEwcjhIMDI5N3VPeUhOaE5ZWi1rbnlEbm9nV2o3RW93MzJjRkNoNm9YN21XdXA2dlR5S0R0RWc?oc=5","date":"2017-01-29","type":"regulatory","source":"Pharmaceutical Online","summary":"Watson Receives FDA Approval Of Potassium Chloride Extended-Release Capsules - Pharmaceutical Online","headline":"Watson Receives FDA Approval Of Potassium Chloride Extended-Release Capsules","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPRS1rTjRsQW51STEzVGxmTFFVMlo2Y0JydWVEd0NQNXZLd01aelB6YnlsZVhKS251ZzlvdVk1aFFRYXNqQTFkcU5tSUdPX3pjVDdqMHI3M1BaR1RjbmZpd1puSk42ajZ3b0FkdjNvSkQyb1p6LVU5dDBzeHk1Vi0xa252OE4xX3JMRjIzakkxY1ZUZjlnUXpUZDl4Z0VlLWdDRlV0dA?oc=5","date":"2013-05-20","type":"pipeline","source":"thestreet.com","summary":"Ireland Welcomes Watson Pharmaceuticals, an American Success - thestreet.com","headline":"Ireland Welcomes Watson Pharmaceuticals, an American Success","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNUUNDOTVudmJFblNSNHZrQnhKa25tT0VpLTlUTFlzaGdLX3VQN0paanJ3bHVKSTBMT1FIS2VoOFVjM2dlUFF2SVV0S0FNQTVVZVNVdW9xcE00LVp3RlZFOGpacGM4ZnJqMlZET2pSMlhiQTA4Rzk0dEV6V0pZNy0zZDVrbWZRd3Y0dExqYUJVRm1Hc2t0WUM2Y3A0SWFsQ19hRTBZMFIxWXRmcVJmSEdjR0hDdlNJMGQxX3JjQQ?oc=5","date":"2013-03-25","type":"patent","source":"AstraZeneca","summary":"AstraZeneca settles litigation over CRESTOR patent - AstraZeneca","headline":"AstraZeneca settles litigation over CRESTOR patent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNcV9ONGFuWld5eUlqSk90TnVjS0ZhUlBCenJtSndZRXR4RjV1cXB6aVo3ZGlMTUJGdW1jRzJLTjlNQkEzNzUzaDdvYmNkZUlfOV9WNTFoTXplbFJ4eTVjdHZHOEVqOUVTcml4bExyd3JLZ09RVHRsRVd1SHE3SXIxN1ZCRWZQNE910gGOAUFVX3lxTE9OLWdwaG40dW9ORjg0S2RyOTR1aUhnTUdrYVNZTkNIUjQwUzloS09pMTc2VE5nVWhmYnBXSUZ4QXdTRXY4QTZwX3JGdGJVV1J6M3VqMDY4anZJVUJGYk9yMnJoM2h5QkZqSEYwczFkSkdHTkd2ZGhieGN5WTd0YlZFdUswYXZYa3lIYUlfNFE?oc=5","date":"2012-10-12","type":"regulatory","source":"CNBC","summary":"Watson's Generic Avapro® Receives FDA Approval - CNBC","headline":"Watson's Generic Avapro® Receives FDA Approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQVFU3WVNfNlk2b0t0WTg1M1cyVlRxVXI2OGxuSmhaWEpXalBxd2trSEk4OGtvYXdQclA2blZrTWZ6Mlh3OFAyM3Fra0xxczU2MzJaMW0xdkQzTzl4V2ZEOXdjckQ3a2VYSl9hSjdnak84ZVd0WllXWE5aYzJOeVpvMTBjWXplbjdXSHA5aTVsMHNiWEttcmNiZdIBVEFVX3lxTE45UEtJWlpWSnRJTllHWUdVb2hLeHB6WmpPdXhTVjBEaVUzdWtpXzNOYjVmUkFtUUt5bWFwLWtYenpNcGF6VE5Qa3BEY0pOWW0zaXRSeg?oc=5","date":"2012-04-25","type":"patent","source":"Law360","summary":"Purdue Seeks To Stop Watson's Reformulated Oxy Generic - Law360","headline":"Purdue Seeks To Stop Watson's Reformulated Oxy Generic - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQVlBtR2JDaFEwNlNCVmJtWDVfN2J1M19RUmx4M2xUR281am90Z0YwWmxOTHl1bVVQVnc4eTV2UDVzUUh0VWxrVUF4MWJQRGxzUWNQbGVuUFMyOVc4MFF4a0FBM05vMkpmMjQzOERoQ1RiUFJGRkZaMkZMd19zeHFwU2FEYzNlRThSUnc?oc=5","date":"2010-05-25","type":"patent","source":"Fierce Pharma","summary":"Watson Confirms Renvela® Patent Challenge - Fierce Pharma","headline":"Watson Confirms Renvela® Patent Challenge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOZWQtR2pzMl8tRXBpLVlDUHB6VklKMEtvUUd0aWlmVkRzTEl3aHFLb2h3UDBjSlhITmYzVVlrNmhfRlMtR2ZwTTVweHdhbWpWVmw3Y3loR1RZWmllQ0FwODh5Y21XZHlNMFFyQm83ZjBLTE9FbXVWc0tYZ1RzUVJnbTZVb1piNzJJZHFyWHVob1JnMDVvallXbWlfZUlaQmpRa0RRNUJ4ZXNJNWw1ZlpzVA?oc=5","date":"2008-12-29","type":"regulatory","source":"Fierce Biotech","summary":"Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R) - Fierce Biotech","headline":"Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}